The Effect of Physostigmine and Tetrabenazine on Spinal Motor Control and its Inhibition by Drugs which Influence Reserpine Rigidity

  • I. Jurna
  • C. Theres
  • T. Bachmann


The effect of monoaminergic (DOPA, metamphetamine, propylhexedrine) and cholinolytic agents (atropine, biperiden, caramiphen, trihexyphenidyl) on spinal motor control disturbed by physostigmine and tetrabenazine was studied in the rat. In addition the anticonvulsant agent phenytoin was included in the investigation. Physostigmine and tetrabenazine produced rigidity, increased a reflex discharge, shortened the latency of α reflex discharge and decreased γ reflex discharge. Rigidity as well as the action of physostigmine and tetrabenazine on α motor activity were inhibited by the drugs. The results are in accordance with the hypothesis that parkinsonlike rigidity in the rat results from hyperactivity of the α motor system, which is due to an imbalance between monoaminergic and cholinergic mechanisms in the brain.


Spinal Motor Activity Physostigmine Tetrabenazine Monoaminergic Agents Cholinolytic Agents Antiparkinson Drugs Phenytoin. 


Die Wirkung von monoaminergen (DOPA, Metamphetamin, Propylhexedrin) und cholinolytischen (Atropin, Biperiden, Caramiphen, Trihexyphenidyl) Substanzen auf die durch Physostigmin und Tetrabenazin gestörte Kontrolle der spinalen Motorik wurde an Ratten geprüft. Zusätzlich wurde das Anticonvulsivum Phenytoin in die Untersuchung einbezogen. Unter dem Ein-fluß von Physostigmin und Tetrabenazin entwickelte sich ein Rigor, die reflektorische Entladung von α-Motoneuronen wurde gesteigert, die Latenz der reflektorischen α-Entladung verkürzt und die Aktivität der γ-Motoneurone vermindert. Die monoaminergen und cholinolytischen Substanzen dämpften den Rigor und die gesteigerte Reflexaktivität der α-Motoneurone. Die Befunde stehen in Einklang mit der Ansicht, daß der parkinsonähnliche Rigor der Ratte auf einer Hyperaktivität des α-motorischen Systems beruht, die ihrerseits Folge des gestörten Gleichgewichtes zwischen monoaminergen und cholinergen Systemen des Gehirns ist.


Spinalmotorische Aktivität Physostigmin Tetrabenazin Monoaminergica Cholinolytica Antiparkinsonstoffe Phenytoin. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arvidsson, J., B.-E. Roos, and G. Steg: Reciprocal effects on α-and γ-motoneurones of drugs influencing monoaminergic and cholinergic transmission. Acta physiol. scand. 67, 398–404 (1966).PubMedCrossRefGoogle Scholar
  2. Carlsson, A.: Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Handbuch der experimentellen Pharmakologie. V. Espamer, Ed. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  3. Esplin, D.W.: Effects of diphenylhydantoin on synaptic transmission in cat spinal cord and stellate ganglion. J. Pharmacol. exp. Ther. 120, 301–323 (1957).PubMedGoogle Scholar
  4. Jurna, I.: Depression by antiparkinson drugs of reserpine rigidity. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 80–88 (1968).CrossRefGoogle Scholar
  5. —, and G. Lanzer: Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 262, 309–324 (1969).CrossRefGoogle Scholar
  6. —, and B. Regélhy: The antagonism between reserpine and some antiparkinson drugs in electroseizure. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 259, 442–459 (1968).CrossRefGoogle Scholar
  7. Pletscher, A., A. Brossi, and K.F. Gey: Benzoquinolizine derivatives: a new class of monoamine decreasing drugs with psychotropic action. Int. Rev. Neurobiol. 4, 275–306 (1962).Google Scholar
  8. Quinn, G.P., P.A. Shore, and B.B. Brodie: Biochemical and pharmacological studies of Ro 1-9569 (tetrabenazine), a non-indole tranquilizing agent with reserpine-like effects. J. Pharmacol. exp. Ther. 127, 103–109 (1959).PubMedGoogle Scholar
  9. Raines, A., and F.G. Standaert: An effect of diphenylhydantoin on posttetanic hyperpolarization of intramedullary nerve terminals. J. Pharmacol. exp. Ther. 156, 591–597 (1967).PubMedGoogle Scholar
  10. Roos, B.-E., and G. Steg: The effect of l-DOPA and 5-HTP on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamine. Life Sci. 3, 351–360 (1964).PubMedCrossRefGoogle Scholar
  11. Steg, G.: Efferent muscle innervation and rigidity. Acta physiol. scand. 61, suppl. 225 (1964).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1969

Authors and Affiliations

  • I. Jurna
    • 1
    • 2
  • C. Theres
    • 1
  • T. Bachmann
    • 1
  1. 1.Institut für Pharmakologie und ToxikologieUniversität des SaarlandesHomburg (Saar)Deutschland
  2. 2.Pharmakologisches Institutder Universität des SaarlandesHomburg/SaarDeutschland

Personalised recommendations